13,6 %Among symptomatic participants, 13.6% had moderate COVID-19 symptoms.
NigeriaCOVID-19HAL · Unilimdocument de 63 observations
Palier Gold : evidences validées mécaniquement, avec leur source primaire.
209 evidences · page 1 / 9
13,6 %Among symptomatic participants, 13.6% had moderate COVID-19 symptoms.
NigeriaCOVID-19HAL · Unilimdocument de 63 observations
SARS-CoV-2 IgGs were detected only in goats from Ebonyi and pigs from Ogun States.
NigeriaCOVID-19publié 2023Viruseseurope_pmcdocument de 6 observationsDOI 10.3390/v15051187
3,52 aORHypertension was associated with increased odds of severe SARS-CoV-2 disease (adjusted odds ratio 3.52, 95% CI: 1.46–8.50).
NigeriaCOVID-19observé April to July 2020publié 2022The Pan African medical journalPubMeddocument de 13 observations
0,043 p-valueThe frequency of respiratory failure was significantly higher in COVID-19 patients with diabetes mellitus (p=0.043).
NigeriaCOVID-19 · diabète (non précisé)publié 2022West African journal of medicinePubMeddocument de 15 observations
50 %Diabetes was seen in 50% of patients.
NigeriaCOVID-19 · diabète (non précisé)publié 2021Cardiovascular journal of AfricaPubMeddocument de 8 observations
97,5 %Most participants with positive SARS-CoV-2 RT-PCR were asymptomatic (97.5%) in Kenya, Uganda, Tanzania, and Nigeria between 19 July 2022 and 1 March 2024.
Kenya · Nigeria · Ouganda · TanzanieCOVID-19observé 19 July 2022 to 1 March 2024publié 2025BMC infectious diseasesPubMeddocument de 8 observations
0 deathsThere were no recorded deaths among the first 32 COVID-19 patients.
NigeriaCOVID-19observé 2020publié 2020The Pan African medical journaleurope_pmcdocument de 9 observations
64,6 %The commonest symptoms were cough (42; 64.6%), breathlessness (41; 63.1%), fever (40; 61.5%), muscle aches (40; 61.5%), and anosmia (16; 24.6%).
NigeriaCOVID-19observé June 2020 to March 2021publié 2022West African journal of medicinePubMeddocument de 9 observations
17,2 %Diabetes prevalence was 17.2% among RT-PCR-negative patients and 9.4% among RT-PCR-positive patients.
NigeriaCOVID-19 · diabète (non précisé)observé 27 February 2020 to 30 September 2020publié 2021The Nigerian postgraduate medical journalPubMeddocument de 12 observations
9,2 %6 deaths (9.2%) were recorded among patients with advanced comorbidities and severe sepsis.
NigeriaCOVID-19observé June 2020 to March 2021publié 2022West African journal of medicinePubMeddocument de 9 observations
16 %Sixteen percent (16%) of the patients were asymptomatic.
NigeriaCOVID-19observé 2020publié 2020The Pan African medical journaleurope_pmcdocument de 9 observations
34,7 %Sixty (34.7%) patients had underlying medical conditions, mostly hypertension and diabetes mellitus.
NigeriaCOVID-19observé 2020publié 2020West African journal of medicinePubMeddocument de 8 observations
16 %In-hospital mortality among COVID-19 patients in this single-center study was 16%.
NigeriaCOVID-19observé 2020publié 2020The American journal of tropical medicine and hygieneeurope_pmcdocument de 8 observations
60 %The lowest median score in any domain for Patent Medicine Stores was 60% for both post-testing phase and safety in COVID-19 antigen rapid diagnostic testing evaluation in the Federal Capital Territory of Nigeria between September 2022 and February 2023.
NigeriaCOVID-19observé September 2022 to February 2023publié 2024PloS onePubMeddocument de 5 observations
22,3 %22.3% of participants were partially vaccinated against COVID-19.
NigeriaCOVID-19observé April-June 2024publié 2026Transactions of the Royal Society of Tropical Medicine and HygienePubMeddocument de 8 observations
1,43 AORKnowing someone who died from COVID-19 was associated with increased odds of fear related to COVID-19 (adjusted odds ratio: 1.43).
NigeriaCOVID-19observé 2020publié 2022Frontiers in public healthPubMeddocument de 10 observations
87 %Among the 45 COVID-19 patients, 87% were male.
NigeriaCOVID-19observé 2020publié 2020The American journal of tropical medicine and hygieneeurope_pmcdocument de 8 observations
38 %The pooled prevalence of SARS-CoV-2 infection among residents of care homes and patients was 38%.
NigeriaCOVID-19publié 2025Journal of public health in Africaeurope_pmcdocument de 4 observations
3,88 AORLiving with HIV was associated with increased odds of fear related to COVID-19 (adjusted odds ratio: 3.88).
NigeriaCOVID-19 · VIH/sidaobservé 2020publié 2022Frontiers in public healthPubMeddocument de 10 observations
17 %The pooled mortality estimate for SARS-CoV-2 infection was 17%.
NigeriaCOVID-19publié 2025Journal of public health in Africaeurope_pmcdocument de 4 observations
30,5 %Among people living with HIV in Federal Capital Territory, Nigeria, COVID-19 vaccine uptake was 30.5% in females and 46.1% in males.
NigeriaCOVID-19publié 2025Transactions of the Royal Society of Tropical Medicine and HygienePubMeddocument de 3 observations
2,49 AORLiving with HIV was associated with increased odds of depression related to COVID-19 (adjusted odds ratio: 2.49).
NigeriaCOVID-19 · VIH/sidaobservé 2020publié 2022Frontiers in public healthPubMeddocument de 10 observations
41 804 casesNigeria had 41,804 confirmed SARS-CoV-2 cases as of 29 July 2020.
NigeriaCOVID-19observé 29 July 2020HAL · Unilimdocument de 97 observations
97 %Almost all (97%) the patients were treated with lopinavir-ritonavir.
NigeriaCOVID-19observé 2020publié 2020The Pan African medical journaleurope_pmcdocument de 9 observations
1,125 odds_ratioThe odds of a patient with diabetes and COVID-19 developing acute kidney injury were 1.125 (95% CI 1.025–1.621).
Nigeriaacute kidney injury · COVID-19 · diabète (non précisé)publié 2022West African journal of medicinePubMeddocument de 15 observations
Chaque ligne mène à son document source. Le nombre indiqué est celui des observations VALIDÉES qu'il porte, jamais celui des observations extraites : les deux diffèrent sur la plupart des documents. L'extrait exact du texte source n'est pas publié, par contrainte de droit d'auteur.